Seronegative Spondyloarthropathies and Connective Tissue Disease - PowerPoint PPT Presentation

About This Presentation
Title:

Seronegative Spondyloarthropathies and Connective Tissue Disease

Description:

Seronegative Spondyloarthropathies and Connective Tissue Disease Victor Politi, M.D., FACP Medical Director, SVCMC, School of Allied Health, Physician Assistant Program – PowerPoint PPT presentation

Number of Views:306
Avg rating:3.0/5.0
Slides: 62
Provided by: VictorP150
Category:

less

Transcript and Presenter's Notes

Title: Seronegative Spondyloarthropathies and Connective Tissue Disease


1
Seronegative Spondyloarthropathies and Connective
Tissue Disease
  • Victor Politi, M.D., FACP
  • Medical Director, SVCMC, School of Allied Health,
    Physician Assistant Program

2
Connective tissue disease
  • A connective tissue disease is any disease that
    has the connective tissues of the body as a
    primary target of pathology.
  • Many connective tissue diseases feature abnormal
    immune system activity with inflammation in
    tissues as a result of an immune system that is
    directed against one's own body tissues
    (autoimmunity).

3
Connective tissue disease
  • Diseases in which inflammation or weakness of
    collagen tends to occur are also referred to as
    collagen diseases.
  • Collagen vascular disease is a somewhat
    antiquated term used to describe diseases of the
    connective tissues that typically include
    diseases which can be (but are not necessarily)
    associated with blood vessel abnormalities.

4
Heritable Connective Tissue Disorders
  • Marfan Syndrome - a genetic disease causing
    abnormal fibrillin.
  • Epidermolysis bullosa (EB). With these disorders,
    the skin blisters when it is stressed. For
    example, a hug could cause a blister.
  • Ehlers-Danlos syndrome - causes progressive
    deterioration of collagens, with different EDS
    types affecting different sites in the body, such
    as joints, heart valves, organ walls, arterial
    walls
  • Osteogenesis imperfecta (brittle bone disease) -
    caused by insufficient production of good quality
    collagen to produce healthy, strong bones.

5
Marfan Syndrome
  • A hereditary disorder of connective tissue
    characterized by tall stature, elongated
    extremities, subluxation of the lens, dilatation
    of the ascending aorta, and "pigeon breast." It
    is inherited as an autosomal dominant trait.

6
Marfan Syndrome
  • Initial diagnosis is made on the basis of a
    careful examination of the three main affected
    areas the heart, skeleton and eyes.

7
(No Transcript)
8
Ehlers-Danlos syndrome (EDS)
  • Ehlers-Danlos syndrome (EDS) is a heterogeneous
    group of heritable connective tissue disorders
    characterized by articular hypermobility, skin
    extensibility and tissue fragility.
  • At this time, research statistics of EDS show the
    prevalence as 1 in 5,000. It is known to affect
    both males and females of all racial and ethnic
    backgrounds.

9
Ehlers-Danlos syndrome (EDS)
  • Clinical manifestations of EDS are most often
    joint and skin related and may include
  • Joints joint hypermobility loose/unstable
    joints which are prone to frequent dislocations
    and/or subluxations joint pain hyperextensible
    joints early onset of osteoarthritis.
  • Skin soft velvetlike skin variable skin
    hyper-extensibility fragile skin that tears or
    bruises easily severe scarring slow and poor
    wound healing development of molluscoid pseudo
    tumors .

10
(No Transcript)
11
SLE
  • Inflammation of the connective tissues.
  • characterized by antinuclear antibodies and
    multiorgan involvement.
  • Peak incidence of systemic lupus erythematosus is
    in people aged 15-40 years, with a female-to-male
    ratio of at least 51.
  • It is up to 9x more common in women than men.

12
SLE
  • The criteria include malar rash, discoid rash,
    photosensitivity, oral ulcers, arthritis,
    serositis, renal disorder, neurologic disorder,
    hematologic disorder, immunologic disorder, and
    positive ANA.

13
Rheumatoid Arthritis
  • Rheumatoid arthritis is a chronic inflammatory
    systemic disease primarily characterized by
    diarthrodial joint involvement.
  • The prevalence of rheumatoid arthritis increases
    with age and has a peak incidence in persons aged
    40-60 years, with a female-to-male ratio of 31.

14
RH
15
Rheumatoid Arthritis
  • The criteria include morning stiffness for at
    least 1 hour, arthritis of 3 or more joint areas,
    arthritis of the hands, symmetric arthritis,
    rheumatoid nodules, serum RF, and radiographic
    changes.
  • RF is found in the serum of approximately 85 of
    patients with rheumatoid arthritis.

16
(No Transcript)
17
Scleroderma
  • Scleroderma is an activation of immune cells
    which produces scar tissue in the skin, internal
    organs, and small blood vessels.
  • It affects women 3x more often than men overall,
    but increases to a rate 15 x gt for women during
    childbearing years.

18
Sjögren's syndrome
  • A chronic, slowly progressing inability to
    secrete saliva and tears.
  • It can occur alone or with rheumatoid arthritis,
    scleroderma, or systemic lupus erythematosus.
  • Nine out of 10 cases occur in women, most often
    at or around mid-life.

19
Sjögrens syndrome
  • The classic clinical presentation for Sjögren
    syndrome is the combination of dry eyes
    (keratoconjunctiva sicca) and dry mouth
    (xerostomia).
  • The criteria for diagnosis of primary Sjögren
    syndrome include symptoms and objective signs of
    ocular dryness, symptoms and objective signs of
    dry mouth, and serologic evidence of a systemic
    autoimmunity by the presence of RF, ANA, or
    antibodies to SSA (Ro) or SSB (La).

20
Sjögrens syndrome
  • Primary Sjögren syndrome may involve multiple
    organs other than the eyes and mouth.
  • Secondary Sjögren syndrome occurs when the
    symptoms and signs of Sjögren syndrome are
    present with another connective-tissue disease
    and most frequently with rheumatoid arthritis.

21
(No Transcript)
22
Polymyositis/dermatomyositis
  • The diagnosis is uncommon, with an incidence
    range from 2-10 cases per million.
  • A bimodal age distribution exists, with peaks at
    ages 10-15 years and at ages 45-60 years
  • The overall female-to-male ratio is 31.

23
Polymyositis/dermatomyositis
  • The 5 possible criteria for diagnosis are
    symmetrical weakness, elevation of muscle
    enzymes, electromyographic evidence, muscle
    biopsy evidence, and dermatologic features.
  • A definite diagnosis of polymyositis must include
    4 criteria without a rash.
  • The diagnosis of dermatomyositis is made when 3
    criteria are present plus the rash.

24
(No Transcript)
25
(No Transcript)
26
(No Transcript)
27
(No Transcript)
28
(No Transcript)
29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
(No Transcript)
33
Reactive Arthritis
  • HLA-B27 positive (50-80 of cases)
  • Formerly called Reiters Syndrome
  • Tetrad of urethritis,conjunctivitis/uveitis,mucocu
    taneous lesions (mouth ulcers) and aseptic
    arthritis (oligoarthritis)
  • Most common in young men
  • Often follows infection

34
Reactive Arthritis
  • Most cases develop days - weeks following
    dysenteric infection (shigella, salmonella,
    yersinia, Campylobacter) or sexually transmitted
    disease (chlamydia trachomatis or Ureaplasma
    urealyticum)
  • To be distinguished from GC arthritis(migratory
    polyarthralgias) and non GC acute bacterial
    (septic) arthritis ie staph.

35
Reactive Arthritis
  • Arthritis - usually asymmetric - involving large
    weight bearing joints (knees, ankle)
  • In 20 of cases - sacroiliitis or ankylosing
    spondylitis present
  • systemic symptoms - fever weight loss common at
    initial stage of disease
  • Other symptoms -
  • mucocutaneous lesions
  • carditis aortic regurgitation may occur

36
Reactive Arthritis
  • Most signs of the disease disappear within days
    to weeks
  • arthritis symptoms however may persist for months
    or years
  • common for recurrences - can involve any
    combination of clinical manifestations - can be
    followed by permanent sequelae (joints)

37
Reactive Arthritis- differential dx
  • Gonococcal arthritis can mimic reactive arthritis
  • however, in gonococcal arthritis
  • marked improvement 24-48 hrs after antibiotics
  • culture results distinguish two disorders
  • also must consider rheumatoid arthritis,
    ankylosing spondylitis and psoriatic arthritis
  • no association between HIV and reactive arthritis

38
Reactive Arthritis - Tx
  • NSAIDs
  • tetracycline's
  • sulfasalazine
  • Anti-TNF agents (etanercept, infliximab)

39
Psoriatic Arthritis
  • In 15-20 of psoriasis patients arthritis
    coexists
  • There are several subsets of arthritis that may
    accompany psoriasis
  • joint disease resembles RA, polyarthritis -
    symmetric, fewer joints involved than in RA
  • oligoarticular form - considerable destruction of
    affected joints

40
Psoriatic Arthritis
  • disease pattern where distal interphalangeal
    joints primarily affected ,pitting of nails,
    onycholysis frequent
  • arthritis mutilans (severe deforming- with marked
    osteolysis) pencil in cup deformity
  • spondylitic form (primary involvement -
    sacroiliitis, spinal involvement) 50 of cases
    HLA-B27 positive

41
Psoriatic Arthritis
  • Psoriasis usually precedes arthritis in 80
  • 20 of cases it occurs simultaneously
  • patient may have a single patch of psoriasis and
    unaware of its connection to arthritis
  • psoriasis may not be present at time of exam
    (important to obtain personal history)

42
Psoriatic Arthritis- Radiographic findings
  • Help distinguish it from other forms of arthritis
  • marginal erosions of bone
  • irregular destruction of joint and bone
  • phalanx may appear - sharpened pencil
  • paravertebral ossification
  • fluffy periosteal new bone -
  • _at_ insertion of muscles and ligaments into bone,
    shafts of metacarpals, metatarsals and phalanges

43
Psoriatic Arthritis- Treatment
  • Symptomatic
  • NSAIDs
  • methotrexate
  • PUVA therapy for skin lesions
  • Corticosteroids (less effective in psoriatic
    arthritis may exacerbate psoriasis)
  • antimalarials may also exacerbate psoriasis

44
Arthritis with GI symptoms
  • 1/5 of patients with inflammatory bowel disease
    have arthritis
  • 2/3 of patients with Whipples disease have
    arthralgia or arthritis (usually episodic/large
    joint polyarthritis) Arthritis usually precedes
    Whipples by years (fever,lymphadenopathy,arthralg
    ias,malabsorption ,infection w/tropheryma
    whippelii.)

45
Arthritis with GI symptoms
  • Two forms of arthritis are seen in Crohns
    disease and ulcerative colitis
  • peripheral arthritis (non deforming asymmetric
    oligoarthritis of large joints)
  • spondylitis (indistinguishable by symptoms or
    x-ray from ankylosing spondylitis)50 of cases
    are HLA-B27-positive

46
  • In most cases arthritis improves with controlling
    intestinal inflammation.

47
Systemic Sclerosis
  • Chronic disorder characterized by diffuse
    fibrosis/thickening of skin ,telangiectasia and
    pigmentation changes
  • Cause unknown
  • 3rd - 5th decade onset
  • Women affected
  • 2 - 3 times more frequently than men

48
Systemic Sclerosis
  • Two Forms
  • limited (80 of cases) CREST syndrome -
    scleroderma limited to face and hands
  • diffuse (20 of cases) trunk and proximal
    extremities also affected

49
CREST Syndrome
50
Scleroderma
51
(No Transcript)
52
CREST Syndrome
  • Calcinosis
  • In scleroderma, calcific deposits are found
    predominantly in the extremities, around joints,
    and around bony prominences.
  • Deposits typically are found in the flexor
    surfaces of the hands and the extensor surfaces
    of the forearms and knees.
  • The deposits rest in the dermis but can be found
    in deeper periarticular tissues.

53
CREST Syndrome
  • Raynaud phenomenon
  • Triphasic color changes of pallor, cyanosis, and
    erythema represent phases of vasoconstriction,
    slow blood flow, and reperfusion, respectively.
  • Color changes extend proximally from the tips of
    digits to various levels, with a well-demarcated
    border.

54
CREST Syndrome
  • Esophageal dysmotility
  • The earliest change in the distal esophagus
    (primarily smooth muscle) is an uncoordinated
    disorganized pattern of contractions resulting in
    low amplitude or absent peristalsis.
  • Lower esophageal sphincter (LES) pressure
    typically is lower than in healthy controls, and
    incomplete relaxation of the LES occurs,
    according to Sjögren.

55
CREST Syndrome
  • Sclerodactyly
  • The process typically begins in the distal
    fingers and advances proximally.
  • The process also may occur on the face, over the
    forehead, and around the mouth. Facial
    involvement can lead to a mauskopf (mouse head)
    appearance. Lips become thinner, and radial
    furrowing develops around the mouth. The oral
    aperture is reduced in size (microstomia).
    Wrinkles over the forehead diminish.

56
CREST Syndrome
  • Telangiectases are flat and nonpulsatile and
    typically have a rectangular or elongated shape.
    The vessels are so close together that they
    appear as discrete mats.

57
Systemic Sclerosis- symptoms/signs
  • Diffuse pulmonary fibrosis
  • GI tract symptoms caused by fibrosis and atrophy
  • hypomotility
  • malabsorption from bacterial overgrowth
  • diverticular develop

58
Systemic Sclerosis- symptoms/signs
  • Renal crisis (usually indicative of poor
    prognosis - though many cases treated
    successfully w/angiotensin-converting enzyme
    inhibitors)
  • Cardiac symptoms
  • pericarditis
  • heart block
  • myocardial fibrosis
  • right heart failure secondary to pulmonary HTN

59
Systemic Sclerosis- Lab findings
  • Mild anemia often present
  • Antinuclear antibody tests - positive
  • Scleroderma antibody (SCL-70) directed against
    topoisomerase III
  • 1/3 of patients w/diffuse systemic sclerosis
  • 20 of patients w/CREST syndrome (anticentromere
    ab seen in 50 crest but 1 of syst. Scler.

60
Systemic Sclerosis - Treatment
  • Symptomatic and supportive
  • Intervention for management of specific organ
    manifestations (ie., Raynaud's syndrome - calcium
    channel blockers, esophageal disease - H2
    blockers, etc.)

61
Questions ??
Write a Comment
User Comments (0)
About PowerShow.com